Relx Plc (NYSE:RELX) Shares Sold by Envestnet Portfolio Solutions Inc.

Envestnet Portfolio Solutions Inc. cut its holdings in Relx Plc (NYSE:RELX - Free Report) by 52.8% during the first quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 21,809 shares of the technology company's stock after selling 24,366 shares during the quarter. Envestnet Portfolio Solutions Inc.'s holdings in Relx were worth $1,099,000 as of its most recent filing with the SEC.

A number of other institutional investors and hedge funds have also made changes to their positions in RELX. Transce3nd LLC purchased a new position in Relx during the 4th quarter worth $40,000. Brown Brothers Harriman & Co. raised its holdings in Relx by 218.5% during the fourth quarter. Brown Brothers Harriman & Co. now owns 965 shares of the technology company's stock worth $44,000 after purchasing an additional 662 shares in the last quarter. Private Trust Co. NA raised its holdings in Relx by 19.2% during the fourth quarter. Private Trust Co. NA now owns 1,237 shares of the technology company's stock worth $56,000 after purchasing an additional 199 shares in the last quarter. Whipplewood Advisors LLC acquired a new stake in Relx in the fourth quarter valued at about $74,000. Finally, Redwood Investments LLC purchased a new stake in Relx in the 4th quarter valued at approximately $120,000. 15.02% of the stock is owned by hedge funds and other institutional investors.

Relx Price Performance

Shares of RELX traded down $0.20 on Wednesday, reaching $53.11. The stock had a trading volume of 952,872 shares, compared to its average volume of 732,626. The firm has a 50-day moving average of $53.67 and a 200 day moving average of $50.23. The company has a quick ratio of 0.47, a current ratio of 0.52 and a debt-to-equity ratio of 1.46. The firm has a market capitalization of $99.73 billion, a PE ratio of 28.55, a PEG ratio of 3.23 and a beta of 0.84. Relx Plc has a twelve month low of $43.45 and a twelve month high of $56.33.

Wall Street Analysts Forecast Growth

Several research firms have recently commented on RELX. Barclays raised Relx from an "equal weight" rating to an "overweight" rating in a report on Friday, March 14th. The Goldman Sachs Group assumed coverage on Relx in a report on Wednesday, March 26th. They issued a "buy" rating for the company. Morgan Stanley restated an "overweight" rating on shares of Relx in a research report on Wednesday, April 16th. Finally, Wall Street Zen cut shares of Relx from a "buy" rating to a "hold" rating in a research note on Tuesday, March 4th. One research analyst has rated the stock with a hold rating, four have issued a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of "Buy".

Relx Company Profile

RELX Plc engages in provision of information and analytics solutions for professional and business customers across industries. It operates through the following business segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. The Scientific, Technical & Medical segment is a global information analytics business that helps institutions and professionals advance healthcare, open science, and improve performance for the benefit of humanity.